Category: BioTech

BioTech, business

Stocks Bounding Upward on Monday: FTD (NASDAQ:FTD), Highpower International (NASDAQ:HPJ), Tesla (NASDAQ:TSLA)

FTD (NASDAQ:FTD) gains nearly 5% Monday, subject of a largely favorable Barron’s weekly article ahead of the online florist’s earnings report this week. FTD was spun off from United Online in November and its shares have barely moved since. Barron’s thinks Wall Street is overlooking the company’s solid balance sheet, with net debt of $191 million, or 25% of total capitalization.   Barron’s says FTD could … Continue reading Stocks Bounding Upward on Monday: FTD (NASDAQ:FTD), Highpower International (NASDAQ:HPJ), Tesla (NASDAQ:TSLA)

John Meady
BioTech

Medical Stocks in the News: Celldex Therapeutics (NASDAQ:CLDX), NeuroMetrix (NASDAQ:NURO)

Celldex Therapeutics (NASDAQ:CLDX) is lower Monday afternoon after its net loss  widened and revenue declined compared to the year-ago period. Results were better than Wall Street’s expectations but could not fend off sellers. In early afternoon action, shares of the biopharmaceutical company are down 11% at $26.15 and traded earlier as low as $25.76. The stock moves within a 52-week range of $9.13 – $38.84. Celldex … Continue reading Medical Stocks in the News: Celldex Therapeutics (NASDAQ:CLDX), NeuroMetrix (NASDAQ:NURO)

Kevin Long
BioTech, business, Finance, news

Magna International (NYSE:MGA) Stock Reaches All Time High; Pacific Ethanol (NASDAQ:PEIX) Surges

Magna International (NYSE:MGA) shares reached their all-time high Monday after the company reported improved Q4 financial results and said it expects fiscal 2014 revenue about in line with estimates. Near midday, Magna International (NYSE:MGA) shares are up 2.5% at $91.32, and earlier hit a record high of $92.42. The automotive supplier reported Q4 earnings of $2.03 per share, compared with the prior-year period’s $1.49 per share. … Continue reading Magna International (NYSE:MGA) Stock Reaches All Time High; Pacific Ethanol (NASDAQ:PEIX) Surges

Colin Pettis
BioTech

Unusual Volume Biotech Stocks: Compugen Ltd (NASDAQ:CGEN), Sinovac Biotech (NASDAQ:SVA), Enzymotec (NASDAQ:ENZY), Cempra (NASDAQ:CEMP)

Over the past three years, using its in-silico discovery platform for predictive drug discovery (i.e. computer models and algorithms), Compugen Ltd. (USA) (NASDAQ:CGEN) has developed a hugely compelling drug Pipeline across several clinical areas. Compugen Ltd. (USA) (NASDAQ:CGEN) stock performance was -20.14% in last session and finished the day at $11.34. Traded volume was 22,668.00 shares in the last session and the average volume of … Continue reading Unusual Volume Biotech Stocks: Compugen Ltd (NASDAQ:CGEN), Sinovac Biotech (NASDAQ:SVA), Enzymotec (NASDAQ:ENZY), Cempra (NASDAQ:CEMP)

Richard Atkins
FB Nasdaq FB Facebook
BioTech

Biotech Stocks Touching New Highs: Clovis Oncology (NASDAQ:CLVS), Vanda Pharmaceuticals (NASDAQ:VNDA), Insys Therapeutics (NASDAQ:INSY), Albany Molecular Research (NASDAQ:AMRI)

Clovis Oncology Inc. reported a fourth quarter loss of $0.92 per share after the bell Thursday, compared to the loss of $0.81 per share last year. Clovis Oncology Inc. (NASDAQ:CLVS) stock performance was 1.58% in last session and finished the day at $79.62. Traded volume was 0.00 shares in the last session and the average volume of the stock remained 589,825.00 shares. The beta of … Continue reading Biotech Stocks Touching New Highs: Clovis Oncology (NASDAQ:CLVS), Vanda Pharmaceuticals (NASDAQ:VNDA), Insys Therapeutics (NASDAQ:INSY), Albany Molecular Research (NASDAQ:AMRI)

Jason Knox
BioTech, Stock Movers

Array Biopharma (NASDAQ:ARRY) Jumping Pre-Bell, SolarCity (NASDAQ:SCTY), Nu Skin Enterprises (NYSE:NUS) Slip

Array BioPharma (NASDAQ:ARRY) was up more than 9% in pre-market trade after reporting positive study results for its asthma treatment. The company said, ARRY-502, an oral CRTh2 antagonist, was studied in a 184-patient placebo-controlled, randomized, double-blind Phase 2 trial in mild to moderate persistent allergic asthma, a population representing more than 12 million patients in the U.S. ARRY-502 met the primary endpoint in the trial, … Continue reading Array Biopharma (NASDAQ:ARRY) Jumping Pre-Bell, SolarCity (NASDAQ:SCTY), Nu Skin Enterprises (NYSE:NUS) Slip

John Meady